These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 37940133)
1. Radiofrequency ablation for papillary thyroid cancer located in isthmus: comparison with that originated in thyroid lobe. Xiao J; Yan L; Li Y; Li X; Yang Z; Zhang M; Luo Y Int J Hyperthermia; 2023; 40(1):2266668. PubMed ID: 37940133 [TBL] [Abstract][Full Text] [Related]
2. Ultrasonography-guided radiofrequency ablation for solitary T1aN0M0 and T1bN0M0 papillary thyroid carcinoma: a retrospective comparative study. Xiao J; Zhang Y; Yan L; Zhang M; Li X; Tang J; Luo Y Eur J Endocrinol; 2021 Dec; 186(1):105-113. PubMed ID: 34757942 [TBL] [Abstract][Full Text] [Related]
3. Clinical outcomes of radiofrequency ablation for solitary T1aN0M0 versus T1bN0M0 papillary thyroid carcinoma: a propensity-matched cohort study. Tong M; Wang L; Gai Z; Zhu Y; Che Y Int J Hyperthermia; 2023; 40(1):2257908. PubMed ID: 37848402 [TBL] [Abstract][Full Text] [Related]
4. Clinical outcomes of radiofrequency ablation for multifocal papillary thyroid microcarcinoma versus unifocal papillary thyroid microcarcinoma: a propensity-matched cohort study. Yan L; Zhang M; Song Q; Xie F; Luo Y Eur Radiol; 2022 Feb; 32(2):1216-1226. PubMed ID: 34357450 [TBL] [Abstract][Full Text] [Related]
5. Comparison of ultrasound-guided radiofrequency ablation versus thyroid lobectomy for T1bN0M0 papillary thyroid carcinoma. Yan L; Li X; Li Y; Xiao J; Zhang M; Luo Y Eur Radiol; 2023 Jan; 33(1):730-740. PubMed ID: 35895122 [TBL] [Abstract][Full Text] [Related]
6. Clinical outcomes of ultrasound-guided radiofrequency ablation for solitary T1N0M0 papillary thyroid carcinoma: A retrospective study with more than 5 years of follow-up. Yan L; Li Y; Li XY; Xiao J; Tang J; Luo Y Cancer; 2023 Aug; 129(16):2469-2478. PubMed ID: 37060239 [TBL] [Abstract][Full Text] [Related]
8. Efficacy and Safety of Thermal Ablation for Solitary Low-Risk T2N0M0 Papillary Thyroid Carcinoma. Fei YL; Wei Y; Zhao ZL; Peng LL; Li Y; Cao SL; Wu J; Zhou HD; Yu MA Korean J Radiol; 2024 Aug; 25(8):756-766. PubMed ID: 39109502 [TBL] [Abstract][Full Text] [Related]
9. Radiofrequency ablation for solitary T1N0M0 papillary thyroid carcinoma in the danger triangle area: a preliminary analysis. Zhang DL; Chen S; Qiu Y; Yang JC; Hong Z; Li J; Wu SS Int J Hyperthermia; 2024; 41(1):2305256. PubMed ID: 38314684 [TBL] [Abstract][Full Text] [Related]
10. Radiofrequency ablation for capsular-located versus noncapsular-located papillary thyroid microcarcinoma: a propensity score matching study of 1095 patients. Jing H; Yan L; Xiao J; Li X; Jiang B; Yang Z; Zhang M; Luo Y Eur Radiol; 2024 Jul; 34(7):4716-4726. PubMed ID: 38170265 [TBL] [Abstract][Full Text] [Related]
11. Ultrasonography-guided radiofrequency ablation vs. surgery for the treatment of solitary T1bN0M0 papillary thyroid carcinoma: A comparative study. Xiao J; Zhang Y; Zhang M; Lan Y; Yan L; Luo Y; Tang J Clin Endocrinol (Oxf); 2021 Apr; 94(4):684-691. PubMed ID: 33128786 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of Ultrasound-Guided Radiofrequency Ablation as a Treatment Option for Papillary Thyroid Microcarcinoma in the Isthmus: A Retrospective Study. Song Q; Gao H; Tian X; Ren L; Lan Y; Yan L; Luo Y Front Endocrinol (Lausanne); 2020; 11():599471. PubMed ID: 33633683 [TBL] [Abstract][Full Text] [Related]
13. Long-Term Outcomes and Risk Factors of Radiofrequency Ablation for T1N0M0 Papillary Thyroid Carcinoma. Li X; Yan L; Xiao J; Li Y; Yang Z; Zhang M; Luo Y JAMA Surg; 2024 Jan; 159(1):51-58. PubMed ID: 37878294 [TBL] [Abstract][Full Text] [Related]
14. Ultrasound-Guided Radiofrequency Ablation He H; Wu R; Zhao J; Song Q; Zhang Y; Luo Y Front Endocrinol (Lausanne); 2021; 12():734432. PubMed ID: 34512557 [TBL] [Abstract][Full Text] [Related]
15. Long-term results of radiofrequency ablation for locally recurrent papillary thyroid carcinoma. Yang Z; Yan L; Xiao J; Li W; Li X; Li Y; Zhang M; Luo Y Int J Hyperthermia; 2023; 40(1):2191912. PubMed ID: 37164353 [TBL] [Abstract][Full Text] [Related]
16. Rigorous radiofrequency ablation can completely treat low-risk small papillary thyroid carcinoma without affecting subsequent surgical management. Li X; Li J; Qiao Z; Yan L; Xiao J; Li Y; Zhang M; Luo Y Eur Radiol; 2023 Jun; 33(6):4189-4197. PubMed ID: 36538070 [TBL] [Abstract][Full Text] [Related]
17. Ultrasonography-guided radiofrequency ablation for the treatment of T2N0M0 papillary thyroid carcinoma: a preliminary study. Xiao J; Zhang Y; Zhang M; Xie F; Yan L; Luo Y; Tang J Int J Hyperthermia; 2021; 38(1):402-408. PubMed ID: 33719861 [TBL] [Abstract][Full Text] [Related]
18. Optimal thyrotropin level for low-risk papillary thyroid carcinoma after ultrasound-guided radiofrequency ablation. Li X; Yan L; Xiao J; Li Y; Zhu Y; Yang Z; Zhang M; Luo Y Int J Hyperthermia; 2023; 40(1):2160880. PubMed ID: 36599433 [TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of radiofrequency ablation in the treatment of low-risk papillary thyroid carcinoma: a review. Ntelis S; Linos D Hormones (Athens); 2021 Jun; 20(2):269-277. PubMed ID: 33822327 [TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of microwave ablation for the treatment of multifocal versus unifocal T1N0M0 papillary thyroid carcinoma: a propensity-matched multicentre retrospective study. Zhao ZL; Dong G; Wang SR; Liu Y; He JF; Shi LL; Guo JQ; Wang ZH; Cong ZB; Liu LH; Yang BB; Qu CP; Wei Y; Peng LL; Li Y; Lu NC; Wu J; Yu MA Eur Radiol; 2023 Dec; 33(12):8727-8735. PubMed ID: 37466709 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]